While the presence of ACPA or RF antibodies has traditionally been considered a poor prognostic factor in RA, it is important to note that not all RA patients exhibit these antibodies, and they may still develop erosive disease. The gene discussed is PRTN3; the disease is rheumatoid arthritis.